WASHINGTON--(BUSINESS WIRE)--Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces the firm's complete portfolio of services to support companies developing, commercializing, utilizing, and investing in innovative digital health technologies. "Players in the digital health space face unique challenges in navigating an ever-changing regulatory landscape, as FDA regulators try to keep up with the pace of digital health technol
Greenleaf Health is a District of Columbia-based FDA regulatory consulting firm that provides compliance, advisory and related services for medical device companies.